ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,502Medicare Part D Prescriptions Filled, Including Refills

Rank: 166 out of 682

$1M Total Retail Price of All Prescriptions

Rank: 105 out of 682

292 Patients Receiving at Least One Drug in Part D
59%Patients 65 Years and Older
81% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 292 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

36% of this provider’s 292 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

2% of this provider’s 10,506 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$74 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

46 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
LISINOPRIL 474 375 1 2
LEVOTHYROXINE SODIUM 420 359 2 3
LACTULOSE 391 351 3 100
NAMENDA 383 365 4 41
HYDROCODONE-ACETAMINOPHEN 351 279 S3 5 1
METFORMIN HCL 321 232 6 8
PRAVASTATIN SODIUM 306 217 7 15
OMEPRAZOLE 278 217 8 5
METOPROLOL TARTRATE 275 207 9 10
EXELON 262 249 10 104
AMLODIPINE BESYLATE 232 193 11 6
CITALOPRAM HBR 219 181 12 17
NEXIUM 208 179 13 19
ALENDRONATE SODIUM 189 183 14 37
POLYETHYLENE GLYCOL 3350 188 152 15 44
DIVALPROEX SODIUM 188 160 15 84
SUBOXONE 183 0 17 169
DONEPEZIL HCL 181 179 18 30
WARFARIN SODIUM 177 113 19 13
TRAZODONE HCL 164 109 20 38
FUROSEMIDE 150 98 21 7
LOVAZA 148 71 22 106
GABAPENTIN 145 134 23 9
PREDNISONE 132 105 24 40
SIMVASTATIN 130 116 25 4
POTASSIUM CHLORIDE 125 101 26 14
DIOVAN 124 112 27 42
LANTUS 121 101 28 55
ATENOLOL 120 71 29 18
ATORVASTATIN CALCIUM 117 111 30 11
INSULIN SYRINGE 115 94 31 75
METOPROLOL SUCCINATE 115 95 31 16
HYDROCHLOROTHIAZIDE 100 61 33 12
CRESTOR 97 71 34 22
ADVAIR DISKUS 96 78 35 47
ESCITALOPRAM OXALATE 95 78 36 73
SERTRALINE HCL 94 80 37 24
TORSEMIDE 89 72 38 155
LEVOFLOXACIN 85 58 39 70
PROMETHAZINE HCL 85 61 R 39 54
NYSTATIN 84 77 41 95
ACTOS 84 75 41 151
MIRTAZAPINE 83 74 43 52
FLUTICASONE PROPIONATE 80 59 44 36
NOVOLIN 70-30 76 59 45 189
ZETIA 75 48 46 69
TRAMADOL HCL 75 55 46 26
CLONIDINE HCL 74 52 48 48
CARVEDILOL 73 60 49 23
PAROXETINE HCL 71 56 50 53
ISOSORBIDE MONONITRATE ER 69 55 51 31
LOVASTATIN 68 52 52 66
CYCLOBENZAPRINE HCL 64 11 R 53 65
GEMFIBROZIL 63 40 54 122
ENOXAPARIN SODIUM 62 61 55 215
NOVOLIN R 61 51 56 167
LANSOPRAZOLE 60 45 57 85
SODIUM CHLORIDE 58 58 58 209
LYRICA 57 53 59 78
TRICOR 56 32 60 94
QUETIAPINE FUMARATE 54 45 61 87
SINGULAIR 54 37 61 63
GLIPIZIDE 53 13 63 61
IBUPROFEN 52 32 64 79
RANITIDINE HCL 52 36 64 28
PHENYTOIN SODIUM EXTENDED 51 49 66 140
CLOPIDOGREL 50 50 67 25
FLUOXETINE HCL 50 26 67 60
SPIRIVA 50 40 67 49
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.